Abstract:In this article, we develop nonparametric inference methods for comparing survival data across two samples, which are beneficial for clinical trials of novel cancer therapies where long-term survival is a critical outcome. These therapies, including immunotherapies or other advanced treatments, aim to establish durable effects. They often exhibit distinct survival patterns such as crossing or delayed separation and potentially leveling-off at the tails of survival curves, clearly violating the proportional hazards assumption and rendering the hazard ratio inappropriate for measuring treatment effects. The proposed methodology utilizes the mixture cure framework to separately analyze the cure rates of long-term survivors and the survival functions of susceptible individuals. We evaluate a nonparametric estimator for the susceptible survival function in the one-sample setting. Under sufficient follow-up, it is expressed as a location-scale-shift variant of the Kaplan-Meier (KM) estimator. It retains several desirable features of the KM estimator, including inverse-probability-censoring weighting, product-limit estimation, self-consistency, and nonparametric efficiency. In scenarios of insufficient follow-up, it can easily be adapted by incorporating a suitable cure rate estimator. In the two-sample setting, besides using the difference in cure rates to measure the long-term effect, we propose a graphical estimand to compare the relative treatment effects on susceptible subgroups. This process, inspired by Kendall's tau, compares the order of survival times among susceptible individuals. The proposed methods' large-sample properties are derived for further inference, and the finite-sample properties are examined through extensive simulation studies. The proposed methodology is applied to analyze the digitized data from the CheckMate 067 immunotherapy clinical trial.

GROUP SEQUENTIAL-METHODS FOR SURVIVAL-DATA USING PARTIAL LIKELIHOOD SCORE PROCESSES WITH COVARIATE ADJUSTMENT

Covariate-adjusted Group Sequential Comparisons of Survival Probabilities

Sequential-Analysis for Censored Regression Data

Sequential Analysis of Cox Model under Response Adaptive Allocation

Covariate-adjusted Survival Analyses in Propensity-Score Matched Samples: Imputing Potential Time-to-event Outcomes.

PENALIZED VARIABLE SELECTION PROCEDURE FOR COX MODELS WITH SEMIPARAMETRIC RELATIVE RISK

An Online Updating Approach for Testing the Proportional Hazards Assumption with Streams of Survival Data

A Simulation-free Group Sequential Design with Max-combo Tests in the Presence of Non-proportional Hazards

Simultaneous variable selection and estimation for survival data via the Gaussian seamless‐L0 penalty

Cause-specific hazard Cox models with partly interval censoring - Penalized likelihood estimation using Gaussian quadrature

Subgroup detection in the heterogeneous partially linear additive Cox model

A Class of Weighted Log-Rank Tests for Survival Data when the Event is Rare

An Empirical Likelihood Approach to Nonparametric Covariate Adjustment in Randomized Clinical Trials

Subgroup detection and sample size calculation with proportional hazards regression for survival data

Long-term effect estimation when combining clinical trial and observational follow-up datasets

Approximating Partial Likelihood Estimators via Optimal Subsampling

Estimand-based Inference in Presence of Long-Term Survivors

Covariate adjustment using propensity scores for dependent censoring problems in the accelerated failure time model

EFFICIENT ESTIMATION OF THE MAXIMAL ASSOCIATION BETWEEN MULTIPLE PREDICTORS AND A SURVIVAL OUTCOME

A Practical Simulation Method to Calculate Sample Size of Group Sequential Trials for Time-to-Event Data under Exponential and Weibull Distribution

Design and Analysis of group-sequential clinical trials based on a modestly-weighted log-rank test in anticipation of a delayed separation of survival curves: A practical guidance